Rankings
▼
Calendar
IRWD FY 2023 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$443M
+7.8% YoY
Gross Profit
$437M
98.6% margin
Operating Income
-$945M
-213.5% margin
Net Income
-$1.0B
-226.4% margin
EPS (Diluted)
$-6.45
Cash Flow
Operating Cash Flow
$183M
Free Cash Flow
$183M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$471M
Total Liabilities
$817M
Stockholders' Equity
-$346M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$443M
$411M
+7.8%
Gross Profit
$437M
$409M
+6.7%
Operating Income
-$945M
$250M
-477.7%
Net Income
-$1.0B
$175M
-672.5%
← Q4 2022
All Quarters
Q1 2023 →